1. Study of Clinicopathological Spectrum and Pattern of Expression of Cyclooxygenase-2 in Urothelial Carcinomas of Bladder.
- Author
-
Bandyopadhyay, Ranjana, Bandyopadhyay, Ujjwal, Chatterjee, Uttara, Naskar, Sukla, Nandy, Sumit, and Basu, Keya
- Subjects
- *
BLADDER cancer genetics , *TRANSITIONAL cell carcinoma , *CLINICAL pathology , *CYCLOOXYGENASE 2 , *GENETIC overexpression - Abstract
Introduction: Overexpression of cyclooxygenase-2 (COX2) in urothelial carcinoma of bladder (UCB) had been studied in the past by different workers and the results were contradictory. The objective of the present study was to evaluate the prognostic implication of COX2 expression in primary urothelial carcinomas of the urinary bladder and its correlation with clinical parameters, tumor stage, grade, and recurrence. Materials and methods: A total of 68 cases who underwent surgery for urothelial carcinoma in our medical college from January 2013 to December 2015 were evaluated in our study. Hematoxylin and eosin-stained slides were examined by two faculties applying standard reporting protocol. Tumor staging and grading was performed as per the WHO guidelines. Immunohistochemistry for expression of COX2 was performed to study any correlation of tumor grade with COX2 expression. The distribution of COX2 positivity was studied in tumors stratified according to established bladder cancer prognostic factor, for example, tumor size, grade, invasion, and spread. Results: Out of 68 cases, 42 cases showed COX2 positivity (61%). In low-grade cases of bladder carcinoma, COX2 positivity was 16 out of 24 cases (60%), and in high-grade cases, COX2 positivity was 10 out of 18 cases (64.28%). Conclusion: In the present study, the association of COX2 overexpression with advanced tumor invasion and tumor grade has been substantiated. Hence, COX2 expression can be taken as a prognostic factor along with other usual prognostic factors in patients of UCB. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF